{"title":"Age and gender-specific reference intervals for uric acid level and hyperuricemia in children with Down syndrome.","authors":"Toshiyuki Kitoh, Tatsuro Yamana, Hirofumi Imura, Fumihito Nozaki, Takashi Kusunoki, Tohru Futami, Tatsuya Fujii","doi":"10.1111/ped.15863","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The association between Down syndrome (DS) and hyperuricemia has been described for a long time. The cut-off points for hyperuricemia should be determined as the upper limits of the uric acid (UA) level according to age- and gender-specific reference UA values prepared for children with DS.</p><p><strong>Methods: </strong>This study included 238 children (140 males and 98 females) with DS, below 21 years of age, who visited our medical center from May 1991 to June 31, 2018. Laboratory data were used to calculate the reference UA levels according to age and gender. We also inquired about the relationship between hyperuricemia and the presence of other diseases and other laboratory findings in children with DS. Fourteen patients had already been definitively diagnosed and treated. The UA data from these cases were excluded from the analysis.</p><p><strong>Results: </strong>The UA levels were significantly higher in all age groups among individuals with DS in comparison with the general population. Newly established reference values revealed 55 patients with hyperuricemia. The prevalence of hyperuricemia in males and females was 25.0% (35/140) and 20.4% (20/98), respectively. The number of hyperuricemia cases increased rapidly after 10 years of age. The UA levels were closely correlated with hemoglobin (Hb) values, creatinine, and total bilirubin, which are closely associated with dehydration in children with DS.</p><p><strong>Conclusions: </strong>These reference levels could help to evaluate hyperuricemia candidates who should be carefully monitored and treated with uric-acid-lowering drugs in the future.</p>","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":"67 1","pages":"e15863"},"PeriodicalIF":1.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatrics International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ped.15863","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The association between Down syndrome (DS) and hyperuricemia has been described for a long time. The cut-off points for hyperuricemia should be determined as the upper limits of the uric acid (UA) level according to age- and gender-specific reference UA values prepared for children with DS.
Methods: This study included 238 children (140 males and 98 females) with DS, below 21 years of age, who visited our medical center from May 1991 to June 31, 2018. Laboratory data were used to calculate the reference UA levels according to age and gender. We also inquired about the relationship between hyperuricemia and the presence of other diseases and other laboratory findings in children with DS. Fourteen patients had already been definitively diagnosed and treated. The UA data from these cases were excluded from the analysis.
Results: The UA levels were significantly higher in all age groups among individuals with DS in comparison with the general population. Newly established reference values revealed 55 patients with hyperuricemia. The prevalence of hyperuricemia in males and females was 25.0% (35/140) and 20.4% (20/98), respectively. The number of hyperuricemia cases increased rapidly after 10 years of age. The UA levels were closely correlated with hemoglobin (Hb) values, creatinine, and total bilirubin, which are closely associated with dehydration in children with DS.
Conclusions: These reference levels could help to evaluate hyperuricemia candidates who should be carefully monitored and treated with uric-acid-lowering drugs in the future.
期刊介绍:
Publishing articles of scientific excellence in pediatrics and child health delivery, Pediatrics International aims to encourage those involved in the research, practice and delivery of child health to share their experiences, ideas and achievements. Formerly Acta Paediatrica Japonica, the change in name in 1999 to Pediatrics International, reflects the Journal''s international status both in readership and contributions (approximately 45% of articles published are from non-Japanese authors). The Editors continue their strong commitment to the sharing of scientific information for the benefit of children everywhere.
Pediatrics International opens the door to all authors throughout the world. Manuscripts are judged by two experts solely upon the basis of their contribution of original data, original ideas and their presentation.